查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
植入式输液泵市场 - 增长、未来前景、竞争分析，2023-2031 年
市场调查报告书
商品编码
1313698

植入式输液泵市场 - 增长、未来前景、竞争分析，2023-2031 年

Implantable Infusion Pumps Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

到2031 年，植入式输液泵市场预计将增长5.2%。植入式输液泵是一种小型设备，通过手术植入皮下，将药物输送到人体的特定区域，减轻疼痛。提供有针对性和持续的药物治疗为了缓解。 支持植入式输液泵市场需求不断增长的主要因素是老年人口的增加、慢性病的流行、医疗保健服务的普及以及私立医院数量的增加。 健康意识的提高导致发达国家和发展中国家人口老龄化的增加，导致住院率上升和种植手术数量增加。 需要术后疼痛管理的慢性疾病的广泛流行也可能对植入式输液泵市场的增长产生积极影响。 医疗保险公司正在让患病的患者更容易获得更好的医疗服务。 私立医院投入大量医疗和福利服务的增加以及向农村地区的扩张将对植入式输液泵的市场渗透率产生积极影响。 然而，这种情况下的挑战是药物戒断引起的潜在并发症、植入部位的疼痛和感染，以及与植入物相关的机械问题（齿轮失速、电池没电），有可能导致严重伤害。 植入式输液泵市场的製约因素包括报销模糊、由于设备复杂性导致产品频繁召回。 不明确的报销政策是医疗保健领域支出的最大障碍，导致在需要药物植入服务的疾病的费用覆盖方面存在歧视。 复杂的泵设计和反復出现的药物输送故障导致频繁的产品召回和巨大的产品研发成本。 这对植入式输液泵的市场渗透率产生了负面影响。

胃肠道并发症、心血管疾病、糖尿病、癌症等主要慢性疾病在北美和欧洲呈上升趋势，疾病认知度高，对微创手术的需求不断增加，预计将推动植入式输液器的增长该地区的泵市场。 然而，来自领先公司的激烈竞争需要在设计和应用方面实现突破性创新，以减少产品召回的可能性和对患者安全的不利影响。 亚太地区、中东和非洲是潜在市场，因为慢性病患病率高，需要立即进行医疗干预，但疾病意识较低。 可以开发偏远和半城市地区未开发的市场。

Codman 和 Shurtleff (CODMAN 3000) 等製造商提供用于慢性疼痛治疗的恆流药物输送。 美敦力 (Medtronics) 提供具有连续血糖监测功能的胰岛素泵。 植入式输液泵市场中观察到的最新产品是渗透泵（ALZET）、球囊泵（Fresenius Kabi AG）。

目录

第一章前言

  • 报告内容
    • 报告的目的
    • 目标受众
    • 提供的主要产品
  • 市场细分
  • 调查方法
    • 第一阶段-二次调查
    • 第二阶段 - 初步调查
    • 第三阶段-专家评审
    • 先决条件
    • 采用的方法

第 2 章执行摘要

第三章植入式输液泵市场：竞争分析

  • 主要供应商的市场地位
  • 供应商采取的策略
  • 主要产业战略
  • 层级分析：2022 年与 2031 年

第四章植入式输液泵市场：宏观分析和市场动态

  • 简介
  • 2021-2031 年全球植入式输液泵市场价值
  • 市场动态
    • 市场驱动因素
    • 市场製约因素
    • 主要挑战
    • 主要机会
  • 促进因素和抑制因素的影响分析
  • 跷跷板分析

第 5 章植入式输液泵市场：2021-2031 年副产品

  • 市场概览
  • 增长/利润分析：2022 年与 2031 年
  • 市场细分
    • 患者自控镇痛 (PCA) 泵
    • 肠内泵
    • 胰岛素泵
    • 弹性体泵
    • 注射泵

第 6 章植入式输液泵市场：按应用划分 2021-2031

  • 市场概览
  • 增长/利润分析：2022 年与 2031 年
  • 市场细分
    • 肿瘤学
    • 儿科/新生儿科
    • 胃肠病学
    • 血液学
    • 糖尿病

第 7 章植入式输液泵市场：按最终用户划分，2021-2031 年

  • 市场概览
  • 增长/利润分析：2022 年与 2031 年
  • 市场细分
    • 医院
    • 门诊手术中心
    • 诊所
    • 家庭医疗护理

第8章北美植入式输液泵市场2021-2031

  • 市场概览
  • 植入式输液泵市场：按产品分类 2021-2031
  • 植入式输液泵市场：按应用划分 2021-2031 年
  • 植入式输液泵市场：按最终用户划分，2021-2031 年
  • 植入式输液泵市场：按地区划分，2021-2031 年
    • 北美
      • 美国
      • 加拿大
      • 其他北美地区

第 9 章英国和欧盟植入式输液泵市场 2021-2031

  • 市场概览
  • 植入式输液泵市场：按产品分类 2021-2031
  • 植入式输液泵市场：按应用划分 2021-2031 年
  • 植入式输液泵市场：按最终用户划分，2021-2031 年
  • 植入式输液泵市场：按地区划分，2021-2031 年
    • 英国和欧盟
      • 英国
      • 德国
      • 西班牙
      • 意大利
      • 法国
      • 其他欧洲地区

第 10 章亚太地区植入式输液泵市场 2021-2031

  • 市场概览
  • 植入式输液泵市场：按产品分类 2021-2031
  • 植入式输液泵市场：按应用划分 2021-2031 年
  • 植入式输液泵市场：按最终用户划分，2021-2031 年
  • 植入式输液泵市场：按地区划分，2021-2031 年
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区

第 11 章拉丁美洲植入式输液泵市场 2021-2031

  • 市场概览
  • 植入式输液泵市场：按产品分类 2021-2031
  • 植入式输液泵市场：按应用划分 2021-2031 年
  • 植入式输液泵市场：按最终用户划分，2021-2031 年
  • 植入式输液泵市场：按地区划分，2021-2031 年
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地区

第十二章中东和非洲植入式输液泵市场2021-2031

  • 市场概览
  • 植入式输液泵市场：按产品分类 2021-2031
  • 植入式输液泵市场：按应用划分 2021-2031 年
  • 植入式输液泵市场：按最终用户划分，2021-2031 年
  • 植入式输液泵市场：按地区划分，2021-2031 年
    • 中东/非洲
      • 海湾合作委员会
      • 非洲
      • 其他中东/非洲地区

第十三章公司简介

  • Codman and Shurtleff
  • I-Flow Corp/Hylard Health
  • Flowobix Medical Inc.
  • Medtronic
  • Tricumed Medizintechnik GmbH.
  • B. Braun Melsungen AG.
  • CareFusion Corporation
  • Fresenius Kabi AG
  • Terumo Corporation
  • Baxter International Inc.
  • Smiths Medical
  • MOOG Inc.
  • Johnson & Johnson Private Ltd.
  • Hospira Inc.
  • Flowonix
  • he Tandem Diabetes Care
  • 其他主要公司
Product Code: 137228-06-23

Implantable infusion pumps market expected to Grow at 5.2% by 2031, Implantable infusion pumps are compact devices that are surgically implanted under the skin to deliver drug to specific parts of the human body, they provide targeted and consistent medication to reduce pain. The major factorial entities supporting the growth in demand for implantable infusion pumps market are rise in geriatric population, wide prevalence of chronic diseases, access to healthcare services and rise in private sector hospitals. Due to better health awareness there has been rise in geriatric population in both the developed and developing nations as a result the rate of hospitalization has increased the number of implant surgeries. Wide prevalence of chronic diseases requiring post-operative pain management will have a positive impact on the growth of the implantable infusion pumps market. Healthcare insurance companies have made it possible for ailing patients to access to better healthcare services. Rise in private sector hospitals spending huge amount on health and welfare and its expansion to rural areas have a positive impact on the deep market penetration of implantable infusion pumps. However, the challenges in this scenario would be drug withdrawal symptoms, pain and infection at the implant site and potential complications arising because of mechanical problems related to implant (gear stopping, battery dying) would lead to serious injury. Restraints regarding the implantable infusion pumps market are ambiguous reimbursement, frequent product recalls due to complexity of the equipment. Ambiguous reimbursement policies cause service discrimination in the cost coverage for the diseases requiring drug implant services which is the biggest hurdle for the expenditure in the healthcare domain. The complexity in the design of the pump and repetitive failure in the drug delivery of the pumps leading to frequent product recalls have led to huge expenditure on the product R&D. This has a negative impact on the market penetration of implantable infusion pumps market.

In North America and Europe there is an increasing number of major chronic diseases like gastrointestinal complications, cardiovascular diseases, diabetes and cancer, high disease awareness and rising demand for minimally invasive surgery is expected to assist the growth of implantable infusion pumps market in these regions. The pitfall being high degree of competition by major players which urges need for path breaking innovation in design and application to reduce the probability of product recalls and adverse impact on patient safety. Asia-Pacific and Middle East and Africa are potential market due to high prevalence of chronic diseases requiring immediate medical intervention but less disease awareness. The untapped market in the remote and semi-urban areas can be captured.

Manufacturers like Codman and Shurtleff (CODMAN 3000) provides constant flow of drug delivery for treatment of chronic pain. Medtronics provides insulin pumps with continuous glucose monitoring. The latest products observed in the implantable infusion pump market are Osmotic pumps (ALZET), Balloon pumps (Fresenius Kabi AG) are employed for better results.

Key players identified for global implantable infusion pumps market include:

Codman and Shurtleff, I-Flow Corp/Hylard Health, Flowobix Medical, Inc., Medtronic, Tricumed Medizintechnik GmbH., B. Braun Melsungen AG., CareFusion Corporation, Fresenius Kabi AG, Terumo Corporation, Baxter International Inc., Smiths Medical, MOOG Inc., Johnson & Johnson Private Ltd., and Hospira, Inc., Flowonix, The Tandem Diabetes Care And Other Notable Players.

This report offers:

  • An overview of the global implantable infusion pumps market.
  • Market trends assessment for the period 2015-2025, with historical information for 2015, and projections through 2025, with respective CAGRs during 2017-2025.
  • Qualitative assessment tools such as market drivers, challenges and future prospects.
  • Market competition scrutiny tools such as market share analysis, fractal map assessment.
  • Focus on each level of market segmentation based on product approvals, launch, and current and anticipated market dynamics.
  • A general overview of the industry structure.
  • Company profiles highlighting key information about the major players operating in the global implantable infusion pumps market.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofImplantable Infusion Pumps market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Implantable Infusion Pumps market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

  • Patient-Controlled Analgesia (PCA) Pump
  • Enteral Pump
  • Insulin Pump
  • Elastomeric Pump
  • Syringe Pump

Application

  • Oncology
  • Pediatrics/Neonatology
  • Gastroenterology
  • Hematology
  • Diabetes

End User

  • Hospitals
  • Ambulatory Surgical Centres
  • Clinics
  • Home Healthcare

Region Segment (2021-2031; US$ Million)

  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Implantable Infusion Pumps market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Implantable Infusion Pumps market?
  • Which is the largest regional market for Implantable Infusion Pumps market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Implantable Infusion Pumps market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Implantable Infusion Pumps market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Implantable Infusion Pumps Market
  • 2.2. Global Implantable Infusion Pumps Market, By Product, 2022 (US$ Million)
  • 2.3. Global Implantable Infusion Pumps Market, By Application, 2022 (US$ Million)
  • 2.4. Global Implantable Infusion Pumps Market, By End User, 2022 (US$ Million)
  • 2.5. Global Implantable Infusion Pumps Market, By Geography, 2022 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2022

3. Implantable Infusion Pumps Market: Competitive Analysis

  • 3.1. Market Positioning of Key Implantable Infusion Pumps Market Vendors
  • 3.2. Strategies Adopted by Implantable Infusion Pumps Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Implantable Infusion Pumps Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Implantable Infusion Pumps Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Patient-Controlled Analgesia (PCA) Pump
    • 5.3.2. Enteral Pump
    • 5.3.3. Insulin Pump
    • 5.3.4. Elastomeric Pump
    • 5.3.5. Syringe Pump

6. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Oncology
    • 6.3.2. Pediatrics/Neonatology
    • 6.3.3. Gastroenterology
    • 6.3.4. Hematology
    • 6.3.5. Diabetes

7. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centres
    • 7.3.3. Clinics
    • 7.3.4. Home Healthcare

8. North America Implantable Infusion Pumps Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
  • 8.3. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
  • 8.4. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
  • 8.5.Implantable Infusion Pumps Market: By Region, 2021-2031, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 8.5.1.1.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.1.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 8.5.1.2.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.2.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 8.5.1.3.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 8.5.1.3.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)

9. UK and European Union Implantable Infusion Pumps Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
  • 9.3. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
  • 9.4. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
  • 9.5.Implantable Infusion Pumps Market: By Region, 2021-2031, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.1.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.1.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.2.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.2.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.3.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.3.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.4.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.4.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.5.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.5.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 9.5.1.6.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 9.5.1.6.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)

10. Asia Pacific Implantable Infusion Pumps Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
  • 10.3. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
  • 10.4. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
  • 10.5.Implantable Infusion Pumps Market: By Region, 2021-2031, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.1.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.1.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.2.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.2.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.3.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.3.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.4.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.4.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.5.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.5.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 10.5.1.6.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 10.5.1.6.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)

11. Latin America Implantable Infusion Pumps Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
  • 11.3. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
  • 11.4. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
  • 11.5.Implantable Infusion Pumps Market: By Region, 2021-2031, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 11.5.1.1.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.1.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 11.5.1.2.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.2.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 11.5.1.3.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 11.5.1.3.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)

12. Middle East and Africa Implantable Infusion Pumps Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
  • 12.3. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
  • 12.4. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
  • 12.5.Implantable Infusion Pumps Market: By Region, 2021-2031, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 12.5.1.1.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.1.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 12.5.1.2.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.2.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Implantable Infusion Pumps Market: By Product, 2021-2031, USD (Million)
        • 12.5.1.3.2. Implantable Infusion Pumps Market: By Application, 2021-2031, USD (Million)
        • 12.5.1.3.3. Implantable Infusion Pumps Market: By End User, 2021-2031, USD (Million)

13. Company Profile

  • 13.1. Codman and Shurtleff
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. I-Flow Corp/Hylard Health
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Flowobix Medical, Inc.
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Medtronic
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Tricumed Medizintechnik GmbH.
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. B. Braun Melsungen AG.
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. CareFusion Corporation
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Fresenius Kabi AG
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Terumo Corporation
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. Baxter International Inc.
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
  • 13.11. Smiths Medical
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Portfolio
    • 13.11.4. Strategic Initiatives
  • 13.12. MOOG Inc.
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Portfolio
    • 13.12.4. Strategic Initiatives
  • 13.13. Johnson & Johnson Private Ltd.
    • 13.13.1. Company Overview
    • 13.13.2. Financial Performance
    • 13.13.3. Product Portfolio
    • 13.13.4. Strategic Initiatives
  • 13.14. Hospira, Inc.
    • 13.14.1. Company Overview
    • 13.14.2. Financial Performance
    • 13.14.3. Product Portfolio
    • 13.14.4. Strategic Initiatives
  • 13.15. Flowonix
    • 13.15.1. Company Overview
    • 13.15.2. Financial Performance
    • 13.15.3. Product Portfolio
    • 13.15.4. Strategic Initiatives
  • 13.16. he Tandem Diabetes Care
    • 13.16.1. Company Overview
    • 13.16.2. Financial Performance
    • 13.16.3. Product Portfolio
    • 13.16.4. Strategic Initiatives
  • 13.17. Other Notable Players
    • 13.17.1. Company Overview
    • 13.17.2. Financial Performance
    • 13.17.3. Product Portfolio
    • 13.17.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 2 Global Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 3 Global Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 4 North America Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 5 North America Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 6 North America Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 7 U.S. Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 8 U.S. Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 9 U.S. Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 10 Canada Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 11 Canada Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 12 Canada Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 13 Rest of North America Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 14 Rest of North America Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 15 Rest of North America Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 16 UK and European Union Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 17 UK and European Union Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 18 UK and European Union Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 19 UK Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 20 UK Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 21 UK Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 22 Germany Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 23 Germany Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 24 Germany Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 25 Spain Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 26 Spain Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 27 Spain Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 28 Italy Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 29 Italy Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 30 Italy Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 31 France Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 32 France Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 33 France Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 34 Rest of Europe Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 35 Rest of Europe Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 36 Rest of Europe Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 37 Asia Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 38 Asia Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 39 Asia Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 40 China Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 41 China Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 42 China Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 43 Japan Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 44 Japan Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 45 Japan Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 46 India Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 47 India Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 48 India Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 49 Australia Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 50 Australia Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 51 Australia Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 52 South Korea Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 53 South Korea Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 54 South Korea Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 55 Latin America Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 56 Latin America Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 57 Latin America Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 58 Brazil Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 59 Brazil Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 60 Brazil Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 61 Mexico Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 62 Mexico Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 63 Mexico Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 64 Rest of Latin America Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 65 Rest of Latin America Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 66 Rest of Latin America Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 67 Middle East and Africa Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 68 Middle East and Africa Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 69 Middle East and Africa Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 70 GCC Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 71 GCC Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 72 GCC Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 73 Africa Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 74 Africa Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 75 Africa Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Implantable Infusion Pumps Market By Product, 2021-2031, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Implantable Infusion Pumps Market By Application, 2021-2031, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Implantable Infusion Pumps Market By End User, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Implantable Infusion Pumps Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Implantable Infusion Pumps Market: Quality Assurance
  • FIG. 5 Global Implantable Infusion Pumps Market, By Product, 2022
  • FIG. 6 Global Implantable Infusion Pumps Market, By Application, 2022
  • FIG. 7 Global Implantable Infusion Pumps Market, By End User, 2022
  • FIG. 8 Global Implantable Infusion Pumps Market, By Geography, 2022
  • FIG. 9 Market Geographical Opportunity Matrix - Global Implantable Infusion Pumps Market, 2022

FIG. 10Market Positioning of Key Implantable Infusion Pumps Market Players, 2022

FIG. 11Global Implantable Infusion Pumps Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031

  • FIG. 12 Global Implantable Infusion Pumps Market, By Product, 2022 Vs 2031, %
  • FIG. 13 Global Implantable Infusion Pumps Market, By Application, 2022 Vs 2031, %
  • FIG. 14 Global Implantable Infusion Pumps Market, By End User, 2022 Vs 2031, %
  • FIG. 15 U.S. Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 16 Canada Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 17 Rest of North America Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 18 UK Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 19 Germany Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 20 Spain Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 21 Italy Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 22 France Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 23 Rest of Europe Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 24 China Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 25 Japan Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 26 India Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 27 Australia Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 28 South Korea Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 29 Rest of Asia Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 30 Brazil Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 31 Mexico Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 32 Rest of Latin America Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 33 GCC Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 34 Africa Implantable Infusion Pumps Market (US$ Million), 2021 - 2031
  • FIG. 35 Rest of Middle East and Africa Implantable Infusion Pumps Market (US$ Million), 2021 - 2031